28.69
-1.08 (-3.63%)
| Penutupan Terdahulu | 29.77 |
| Buka | 29.35 |
| Jumlah Dagangan | 189,559 |
| Purata Dagangan (3B) | 614,740 |
| Modal Pasaran | 1,343,942,912 |
| Harga / Pendapatan (P/E TTM) | 62.37 |
| Harga / Jualan (P/S) | 1.17 |
| Harga / Buku (P/B) | 1.07 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 31 Jul 2025 |
| Margin Keuntungan | 1.87% |
| Margin Operasi (TTM) | -4.31% |
| EPS Cair (TTM) | 0.460 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 55.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 30.69% |
| Nisbah Semasa (MRQ) | 1.38 |
| Aliran Tunai Operasi (OCF TTM) | 163.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 122.12 M |
| Pulangan Atas Aset (ROA TTM) | 0.35% |
| Pulangan Atas Ekuiti (ROE TTM) | 1.73% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Bercampur | Bercampur |
| Health Information Services (Global) | Bercampur | Bercampur | |
| Stok | Omnicell, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | -0.13 |
|
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.78% |
| % Dimiliki oleh Institusi | 104.60% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (Benchmark, 39.42%) | Beli |
| Median | 37.00 (28.97%) | |
| Rendah | 34.00 (B of A Securities, 18.51%) | Pegang |
| Purata | 37.00 (28.97%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 27.03 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| B of A Securities | 23 May 2025 | 34.00 (18.51%) | Pegang | 28.23 |
| Wells Fargo | 23 May 2025 | 37.00 (28.96%) | Beli | 28.23 |
| 14 May 2025 | 35.00 (21.99%) | Beli | 28.73 | |
| Benchmark | 07 May 2025 | 40.00 (39.42%) | Beli | 24.63 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 14 Jul 2025 | Pengumuman | Omnicell to Release Second Quarter 2025 Financial Results on July 31, 2025 |
| 22 May 2025 | Pengumuman | Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program |
| 14 May 2025 | Pengumuman | Omnicell Opens New Innovation Lab in Austin, Texas |
| 14 May 2025 | Pengumuman | Omnicell Announces New Products for Perioperative and Clinic Settings |
| 06 May 2025 | Pengumuman | Omnicell Announces First Quarter 2025 Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |